Andreas Bültmann
University of Tübingen
26 Papers
346 Citations
Andreas Bültmann is an academic researcher from University of Tübingen. The author has contributed to research in topics: GPVI & Platelet activation. The author has an hindex of 16, co-authored 25 publications.
Chat about Author
Papers
Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans
Martin Ungerer,Kai Rosport,Andreas Bültmann,Richard Piechatzek,Kerstin Uhland,Peter Schlieper,Meinrad Gawaz,Götz Münch +7 more
TL;DR: This phase I study demonstrated that Revacept is a safe and well-tolerated new antiplatelet compound with a clear dose-dependent pharmacokinetic profile with specific, dose-related inhibition of platelet aggregation despite completely unaltered general hemostasis.
230
Effect of the oxLDL Binding Protein Fc-CD68 on Plaque Extension and Vulnerability in Atherosclerosis
Stephan Zeibig,Zhongmin Li,Silvia Wagner,Hans-Peter Holthoff,Martin Ungerer,Andreas Bültmann,Kerstin Uhland,Jasmin Vogelmann,Thomas Simmet,Meinrad Gawaz,Götz Münch +10 more
TL;DR: The oxLDL binding protein Fc-CD68 attenuates atherosclerosis and strengthens the stability of atherosclerotic plaques.
73
EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction
Peter Seizer,Oliver Borst,Harald F. Langer,Andreas Bültmann,Götz Münch,Yared Herouy,Konstantinos Stellos,Björn F. Krämer,Boris Bigalke,Berthold Büchele,Max G. Bachem,Dietmar Vestweber,Thomas Simmet,Meinrad Gawaz,Andreas E. May +14 more
TL;DR: In this article, platelet glycoprotein VI (GPVI) was identified as a novel adhesion receptor for EMMPRIN, which can mediate platelet rolling via GPVI-EMMPRIN interaction.
72
•Journal Article
Abstract 3913: Emmprin (cd147) Is a Novel Receptor for Platelet GPVI and Mediates Platelet Rolling via GPVI-Emmprin Interaction
Peter Seizer,Harald F. Langer,Borst Oliver,Andreas Bültmann,Götz Münch,Tanja Schönberger,Björn F. Krämer,Boris Bigalke,Meinrad Gawaz,Andreas E. May +9 more
61
Junctional Adhesion Molecule A Expressed on Human CD34+ Cells Promotes Adhesion on Vascular Wall and Differentiation Into Endothelial Progenitor Cells
Konstantinos Stellos,Harald F. Langer,Stephan Gnerlich,Victoria Panagiota,Angela Paul,Tanja Schönberger,Elena Ninci,Dagmar Menzel,Iris I. Mueller,Boris Bigalke,Tobias Geisler,Andreas Bültmann,Stephan Lindemann,Meinrad Gawaz +13 more
TL;DR: Results indicate that the expression of JAM-A on CD34+ cells mediates adhesion to the vascular wall after injury and differentiation into endothelial progenitor cells, a mechanism potentially involved in vascular regeneration.
53